PTAB Upholds IP Involved In $272M Genetic Testing Verdict
The Patent Trial and Appeal Board dealt LabCorp a blow by rejecting its arguments that 37 claims in a Ravgen Inc. prenatal genetic testing patent — including the claim at the...To view the full article, register now.
Already a subscriber? Click here to view full article